Skip to main content
SCONRES 88 110th Congress Senate Health Drug approvals Estrogen Physicians Women Women's health

A concurrent resolution expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the…

Show full title

A concurrent resolution expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.

Introduced: June 10, 2008 Introduced by: Cornyn, John Republican · Texas See on congress.gov
Sign in to write a letter Sign in to watch
This resolution expired with the 110th Congress
It was not agreed to before the 110th Congress (2007–2008) adjourned, so it is no longer active. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
Jun 10, 2008
Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S5455-5456)
Jun 10, 2008
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Calls for the Food and Drug Administration (FDA) to reverse its policy that aims to eliminate patient access to compounded medications containing estriol prescribed by physicians unless it holds a public comment period on the issue and can document evidence of adverse events and other safety issues to justify such policy.

What's happening now June 10, 2008

Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S5455-5456)

 Related & companion bills 1
  • HCONRES 342 Related bill Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to…
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. Con. Res. 88: A concurrent resolution expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.. 110th Congress. Open America. https://openamerica.io/bill/110-SCONRES-88/
MLA
"S. Con. Res. 88: A concurrent resolution expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.." 110th Congress, 2026, Open America, https://openamerica.io/bill/110-SCONRES-88/.
Bluebook (legal)
S. Con. Res. 88, 110th Cong. (2026), https://openamerica.io/bill/110-SCONRES-88/.
Markdown link
[S. Con. Res. 88: A concurrent resolution expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.](https://openamerica.io/bill/110-SCONRES-88/)
Report a problem